Therini Bio

Therini Biois a clinical-stage biotechnology company developing fibrin-targetedtherapeutics designed to selectively modulate neuroinflammation and vasculardysfunction. Its platform is focused on treating serious neurological andretinal diseases, including Alzheimer’s disease and diabetic macular edema. (Therini Bio)

DealOrigin:

External Dealflow

Location:

South San Francisco, California, USA

Build with

• Katerina Akassoglou/Tara Nickerson
• SV Health Investors / Dementia Discovery Fund (Therini Bio)

‍